Cori Morrison
Pediatric Hematology-Oncology · New Orleans, LANPI 1679743728
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $509 and has fallen 82.7% since, to $88 in 2025. That places this record below the midpoint for pediatric hematology-oncology clinicians in LA, where the typical reported total is $1,449.
Across 74 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$297
- Novo Nordisk$154
- Bioverativ Therapeutics Inc.$110
- Sobi, Inc$103
- Global Blood Therapeutics, Inc.$99
- Servier Pharmaceuticals LLC$83
- plus $603 from 21 others
What the payments were for
- Food & beverage$1,43399%
- Entertainment$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $297 |
| Novo Nordisk | 8 | $154 |
| Bioverativ Therapeutics Inc. | 1 | $110 |
| Sobi, Inc | 5 | $103 |
| Global Blood Therapeutics, Inc. | 6 | $99 |
| Servier Pharmaceuticals LLC | 5 | $83 |
| AstraZeneca(2 entities) | 4 | $73 |
| Pfizer | 4 | $70 |
| CSL Behring | 3 | $62 |
| Eurofins Viracor, LLC | 2 | $52 |
| Bayer | 2 | $34 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Y-mabs Therapeutics, Inc. | 1 | $31 |
| Fennec Pharmaceuticals, Inc. | 1 | $28 |
| Genetix Biotherapeutics Inc | 1 | $21 |
| Octapharma USA, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $21 |
| Avanos Medical | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Adaptive Biotechnologies Corporation | 1 | $18 |
| BTG International Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $17 |
| Seagen Inc. | 1 | $15 |
| Medexus Pharma, Inc. | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $13 |
| Silvergate Pharmaceuticals, Inc. | 1 | $12 |
| Emmaus Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALPROLIX$110
How this compares
$1,449 in reported general payments places this provider in the 50th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in New Orleans
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Zachary LeblancNew Orleans$55K
- Dana LeblancNew Orleans$25K
- Renee GardnerNew Orleans$25K
- Pinki PrasadNew Orleans$20K
- Robert VasquezNew Orleans$6K
- Lolie YuNew Orleans$3K
- Craig LottermanNew Orleans$3K
- Justin FargeNew Orleans$797
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.